Perpetuum CropScience

Perpetuum CropScience is a pioneering biopharmaceutical company founded in 2017, with a strong focus on anti-aging. The company distinguishes itself by leveraging human genetics to inform its entire pipeline, thereby revolutionizing traditional molecule discovery. By starting with human genetics to identify superior targets and then validating these discoveries in preclinical models before moving into clinical trials, Perpetuum aims to mitigate the high failure rates often associated with traditional approaches. Operating from its headquarters in Belgium, the company boasts a proprietary plant-based protein expression platform, which allows for the production of innovative molecules for dermo-cosmetics, aesthetics, and medical device classified products. With expertise in molecular biology, biotechnology, genetics, and proteomics, Perpetuum is dedicated to introducing high-tech solutions for various industries. Despite not having publicly disclosed its recent investment details, Perpetuum CropScience continues to demonstrate promise in the biotech industry.